In other words, non-hypoxic signaling of several diverse oncogenes can mimic the effects of hypoxia and HIF1α and sustain the same metabolic phenotype, continuing to offer a growth advantage and apoptosis inhibition in the growing tumor. This evidence concerns the gene HIF1A and neoplasm.